Evidence map›Paper›PMID 24567125›Full record

ArticleNutrition & diabetes2014

Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects.

P Lopez-Legarrea, R de la Iglesia, A B Crujeiras, M Pardo, F F Casanueva, M A Zulet, J A Martinez

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrition & diabetes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01087086 (Reduction of the Metabolic Syndrome in Navarra-Spain), which is not on this map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01087086 nacompletednot on this map

Reduction of the Metabolic Syndrome in Navarra-Spain (RESMENA-S) Through an Innovative Multidisciplinary Strategy Based on the Crononutrition and Dietary Training Concepts, in Addition to Both Dietary and Psychological Control

TypeinterventionalSponsorClinica Universidad de Navarra, Universidad de NavarraRan2010 to 2011Enrolled109ConditionsMetabolic Syndrome, Obesity, Diabetes, Cardiovascular DiseaseArmsCrononutrition, American Heart Association
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Higher Baseline Serum Irisin Decreases Risk for Body Mass Index Increment in Chinese Populations: A 3.2-Year Cohort Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

P Lopez-Legarrea1] Department of Nutrition, Food Science and Physiology, University of Navarra, Pamplona, Spain [2] Faculty of Health Science, Universidad Autonoma de Chile, Santiago, Chile.
R de la IglesiaDepartment of Nutrition, Food Science and Physiology, University of Navarra, Pamplona, Spain.
A B Crujeiras1] CIBERObn, Carlos III Health Institute, Madrid, Spain [2] Laboratory of Molecular and Cellular Endocrinology, Health Research Institute (IDIS), University of Santiago Hospital Complex (CHUS) and Santiago de Compostela University (USC), Santiago de Compostela, Spain [3] Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
M Pardo1] CIBERObn, Carlos III Health Institute, Madrid, Spain [2] Laboratory of Molecular and Cellular Endocrinology, Health Research Institute (IDIS), University of Santiago Hospital Complex (CHUS) and Santiago de Compostela University (USC), Santiago de Compostela, Spain.
F F CasanuevaLaboratory of Molecular and Cellular Endocrinology, Health Research Institute (IDIS), University of Santiago Hospital Complex (CHUS) and Santiago de Compostela University (USC), Santiago de Compostela, Spain.
M A Zulet1] Department of Nutrition, Food Science and Physiology, University of Navarra, Pamplona, Spain [2] CIBERObn, Carlos III Health Institute, Madrid, Spain.
J A Martinez1] Department of Nutrition, Food Science and Physiology, University of Navarra, Pamplona, Spain [2] CIBERObn, Carlos III Health Institute, Madrid, Spain.
Instituto de Salud Carlos III · ESUniversidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irisin is assumed to be a relevant link between muscle and weight maintenance as well as to mediate exercise benefits on health. The aim of this study was to assess the possible associations between irisin levels and glucose homeostasis in obese subjects with metabolic syndrome (MetS) following an energy-restricted treatment. Ninety-six adults with excessive body weight and MetS features underwent a hypocaloric dietary pattern for 8 weeks, within the RESMENA randomized controlled trial (www.clinicaltrials.gov; NCT01087086). After the intervention, dietary restriction significantly reduced body weight and evidenced a dietary-induced decrease in circulating levels of irisin in parallel with improvements on glucose homeostasis markers. Interestingly, participants with higher irisin values at baseline (above the median) showed a greater reduction on glucose (P=0.022) and insulin (P=0.021) concentrations as well as on the homeostasis model assessment index (P=0.008) and triglycerides (P=0.006) after the dietary intervention, compared with those presenting low-irisin baseline values (below the median). Interestingly, a positive correlation between irisin and carbohydrate intake was found at the end of the experimental period. In conclusion, irisin appears to be involved in glucose metabolism regulation after a dietary-induced weight loss.

Identifiers

PMID24567125
PMCPMC3940831
OpenAlexW2125507553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.